Nesher, Israel

Arie Gutman

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Opko Pharmaceuticals, LLC. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arie Gutman. Retrieved from https://idiyas.com/inventor/arie-gutman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arie Gutman: Innovator in Pharmaceutical Science

Introduction

Arie Gutman is a notable inventor based in Nesher, IL. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that enhance oral bioavailability.

Latest Patents

Gutman holds a patent for "Pure heptasulfated disaccharides having improved oral bioavailability." This invention focuses on hypersulfated disaccharides that have utility in treating asthma or asthma-related disorders. The heptasulfated disaccharides, when administered orally, demonstrate comparable bioavailability to intravenous dosage forms. This advancement could potentially improve treatment options for patients suffering from respiratory conditions.

Career Highlights

Arie Gutman is currently associated with Opko Pharmaceuticals, LLC, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to enhancing drug delivery systems and improving patient outcomes.

Collaborations

Some of his notable coworkers include Tahir Ahmed and Irina Fedotev, who contribute to the collaborative efforts within the company.

Conclusion

Arie Gutman's work exemplifies the intersection of innovation and healthcare, showcasing how advancements in pharmaceutical science can lead to better treatment options for patients. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…